The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke: The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan
Abstract
Background and Purpose— The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan was organized to determine the safety and clinical efficacy of intraarterial infusion of urokinase (UK) in patients with stroke within 6 hours of onset. Methods— Patients with ischemic stroke presenting within 6 hours of onset and displaying occlusions of the M1 or M2 portion of the middle cerebral artery on carotid angiography were randomized to the UK or control groups. Clinical outcome was assessed by the modified Rankin Scale, National Institutes of Health Stroke Scale, and Barthel Index. Results— The Independent Monitoring Committee recommended stopping the trial after approval of intravenous infusion of recombinant tissue plasminogen activator in Japan. A total of 114 patients underwent randomization, 57 patients in each group. Background characteristics were comparable between the 2 groups. The primary end point of favorable outcome (modified Rankin Scale 0 to 2) at 90 days was somewhat more frequent in the UK group than in the control group (49.1% and 38.6%, OR: 1.54, 95% CI: 0.73 to 3.23) but did not reach a significant level ( P =0.345). However, excellent functional outcome (modified Rankin Scale 0 to 1) at 90 days, a preplanned secondary end point, was more frequent in the UK group than in the control group (42.1% and 22.8%, P =0.045, OR: 2.46, 95% CI: 1.09 to 5.54). There were significantly more patients with National Institutes of Health Stroke Scale 0 or 1 at 90 days in the UK group than the control group ( P =0.017). The 90-day cumulative mortality was 5.3% in the UK group and 3.5% in the control group ( P =1.000), and intracerebral hemorrhage within 24 hours of treatment occurred in 9% and 2%, respectively ( P =0.206). Conclusions— The trial was aborted prematurely and the primary end point did not reach statistical significance. Nevertheless, the secondary analyses suggested that intraarterial fibrinolysis has the potential to increase the likelihood of excellent functional outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Hacke, W., Kaste, M., Fieschi, C., von Kummer, R., Davalos, A., Meier, D., Larrue, V., Bluhmki, E., Davis, S., Donnan, G., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)08020-9 · Cited by 3,662
Furlan, A., Higashida, R., Wechsler, L., Gent, M., Rowley, H., Kase, C., Pessin, M., Ahuja, A., Callahan, F., Clark, W. M., et al. (1999) · JAMA · doi:10.1001/jama.282.21.2003 · Cited by 3,073
Albers, G. W., Thijs, V. N., Wechsler, L., Kemp, S., Schlaug, G., Skalabrin, E., Bammer, R., Kakuda, W., Lansberg, M. G., Shuaib, A., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20976 · Cited by 1,268
del Zoppo, G. J., Higashida, R. T., Furlan, A. J., Pessin, M. S., Rowley, H. A., & Gent, M. (1998) · Stroke · doi:10.1161/01.str.29.1.4 · Cited by 1,239
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
del Zoppo, G. J., Poeck, K., Pessin, M. S., Wolpert, S. M., Furlan, A. J., Ferbert, A., Alberts, M. J., Zivin, J. A., Wechsler, L., Busse, O., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410320113 · Cited by 999
Intra-arterial Prourokinase for Acute Ischemic Stroke
Akins, P. T. (2000) · JAMA · doi:10.1001/jama.283.16.2102 · Cited by 792
Lewandowski, C. A., Frankel, M., Tomsick, T. A., Broderick, J., Frey, J., Clark, W., Starkman, S., Grotta, J., Spilker, J., Khoury, J., et al. (1999) · Stroke · doi:10.1161/01.str.30.12.2598 · Cited by 628
Furlan, A. J., Eyding, D., Albers, G. W., Al-Rawi, Y., Lees, K. R., Rowley, H. A., Sachara, C., Soehngen, M., Warach, S., & Hacke, W. (2006) · Stroke · doi:10.1161/01.str.0000217403.66996.6d · Cited by 540
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,468
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
Berkhemer, O. A., Fransen, P. S. S., Beumer, D., van den Berg, L. A., Lingsma, H. F., Yoo, A. J., Schonewille, W. J., Vos, J. A., Nederkoorn, P. J., Wermer, M. J. H., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411587 · Cited by 6,657
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2018) · Stroke · doi:10.1161/str.0000000000000158 · Cited by 5,446
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
(2008) · Cerebrovascular Diseases · doi:10.1159/000131083 · Cited by 2,489
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub3 · Cited by 1,370
Pathophysiology and treatment of stroke: present status and future perspectives
Kuriakose, D., & Xiao, Z. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207609 · Cited by 1,350
Endovascular Treatment for Acute Ischemic Stroke
Ciccone, A., Valvassori, L., Nichelatti, M., Sgoifo, A., Ponzio, M., Sterzi, R., & Boccardi, E. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213701 · Cited by 1,297
The Penumbra Pivotal Stroke Trial Investigators (2009) · Stroke · doi:10.1161/strokeaha.108.544957 · Cited by 959
Schonewille, W. J., Wijman, C. A., Michel, P., Rueckert, C. M., Weimar, C., Mattle, H. P., Engelter, S. T., Tanne, D., Muir, K. W., Molina, C. A., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70173-5 · Cited by 776
Sacks, D., Baxter, B., Campbell, B. C. V., Carpenter, J. S., Cognard, C., Dippel, D., Eesa, M., Fischer, U., Hausegger, K., Hirsch, J. A., et al. (2018) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2017.11.026 · Cited by 686
Acute Stroke Intervention: A Systematic Review
Prabhakaran, S., Ruff, I., & Bernstein, R. A. (2015) · JAMA · doi:10.1001/jama.2015.3058 · Cited by 671
From the American Association of Neurological Surgeons (AANS), A. S. O. N. (., Sacks, D., Baxter, B., Campbell, B. C. V., Carpenter, J. S., Cognard, C., Dippel, D., Eesa, M., Fischer, U., Hausegger, K., et al. (2018) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5638 · Cited by 599
Fransen, P. S., Beumer, D., Berkhemer, O. A., van den Berg, L. A., Lingsma, H., van der Lugt, A., van Zwam, W. H., van Oostenbrugge, R. J., Roos, Y. B., Majoie, C. B., et al. (2014) · Trials · doi:10.1186/1745-6215-15-343 · Cited by 551
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Lansberg, M. G., O'Donnell, M. J., Khatri, P., Lang, E. S., Nguyen-Huynh, M. N., Schwartz, N. E., Sonnenberg, F. A., Schulman, S., Vandvik, P. O., Spencer, F. A., et al. (2012) · Chest · doi:10.1378/chest.11-2302 · Cited by 455
Latchaw, R. E., Alberts, M. J., Lev, M. H., Connors, J. J., Harbaugh, R. E., Higashida, R. T., Hobson, R., Kidwell, C. S., Koroshetz, W. J., Mathews, V., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.192616 · Cited by 452
Bertog, S. C., Sievert, K., Grunwald, I. Q., Sharma, A., Hornung, M., Kühn, A. L., Vaskelyte, L., Hofmann, I., Gafoor, S., Reinartz, M., et al. (2022) · Interventional Cardiology · doi:10.1002/9781119697367.ch71 · Cited by 356
Lima, F. O., Furie, K. L., Silva, G. S., Lev, M. H., Camargo, E. C. S., Singhal, A. B., Harris, G. J., Halpern, E. F., Koroshetz, W. J., Smith, W. S., et al. (2010) · Stroke · doi:10.1161/strokeaha.110.592303 · Cited by 351
Liu, L., Chen, W., Zhou, H., Duan, W., Li, S., Huo, X., Xu, W., Huang, L., Zheng, H., Liu, J., et al. (2020) · Stroke and Vascular Neurology · doi:10.1136/svn-2020-000378 · Cited by 349
The Penumbra System: A Mechanical Device for the Treatment of Acute Stroke due to Thromboembolism
Bose, A., Henkes, H., Alfke, K., Reith, W., Mayer, T. E., Berlis, A., Branca, V., & Sit, S. P. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1110 · Cited by 341
Thrombolysis for acute ischaemic stroke
Wardlaw, J. M., Murray, V., Berge, E., & del Zoppo, G. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000213.pub2 · Cited by 267
Chalos, V., van der Ende, N. A. M., Lingsma, H. F., Mulder, M. J. H. L., Venema, E., Dijkland, S. A., Berkhemer, O. A., Yoo, A. J., Broderick, J. P., Palesch, Y. Y., et al. (2020) · Stroke · doi:10.1161/strokeaha.119.026791 · Cited by 215
Treatment effects for which shift or binary analyses are advantageous in acute stroke trials
Saver, J. L., & Gornbein, J. (2009) · Neurology · doi:10.1212/01.wnl.0000341308.73506.b7 · Cited by 135
Mechanical thrombectomy for the treatment of acute ischemic stroke
Fields, J. D., Lindsay, K., Liu, K. C., Nesbit, G. M., & Lutsep, H. L. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.8 · Cited by 16
Metadata
- Authors
- Ogawa, A., Mori, E., Minematsu, K., Taki, W., Takahashi, A., Nemoto, S., Miyamoto, S., Sasaki, M., & Inoue, T.
- Venue
- Stroke
- Published
- 2007-10
- Volume
- 38
- Issue
- 10
- Pages
- 2633-2639
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2012982706
- Cited by
- 481
- References
- 28
- FWCI
- 22.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.